Lateral shoe wedging for medial knee osteoarthritis

Lateral shoe wedging offers a simple, non-invasive approach to managing medial knee osteoarthritis (OA) by reducing load on the affected medial compartment. This biomechanical intervention has been studied extensively for its potential to alleviate pain and improve function without surgery or medication.

Biomechanics of Medial Knee OA

Medial knee OA involves cartilage degeneration primarily on the inner (medial) side of the tibiofemoral joint, often due to varus alignment where the knee angles inward. This misalignment increases medial compartment loading during weight-bearing activities like walking, exacerbating pain and joint stress.

Lateral shoe wedging counters this by tilting the foot slightly outward (into eversion), which shifts the ground reaction force laterally. A typical wedge, often 5° thick on the lateral heel or full-length sole, reduces the knee adduction moment (KAM)—a key measure of medial load—by 5-12% in responsive patients.

This unloading effect persists over time in many users, with studies showing sustained reductions in peak KAM and knee adduction angle even after one year of use.

These heel wedges, as shown, fit into everyday shoes and subtly realign the lower limb’s frontal plane mechanics to offload the medial knee.

Clinical Evidence on Pain Relief

Multiple randomized controlled trials (RCTs) support lateral wedging for symptom improvement in medial knee OA. A 2024 crossover trial of 62 patients (mean age 64) found lateral wedges reduced knee pain by 0.7 points on a 0-10 scale versus neutral insoles after 8 weeks (P=0.02), with 28% reporting meaningful pain relief.

Earlier studies confirm early benefits: a one-year trial with walking shoes and 5° wedges improved 6-minute walk test pain more than neutral orthoses, alongside gains in walk distance and stair negotiation. Another RCT (n=200) using full-length 5° wedges daily for 12 months showed modest pain reductions on numerical rating scales, though not always superior to flat insoles for all outcomes.

However, response varies—about 25% of patients show no KAM reduction, limiting efficacy in non-responders. Guidelines still recommend wedges as first-line conservative therapy due to low cost and ease.

Effects on Function and Structure

Functional gains accompany pain relief. Participants in wedge trials report better Knee Injury and Osteoarthritis Outcome Scores (KOOS), particularly in activity and quality-of-life domains, comparable to controls but with faster onset.

Structurally, evidence is mixed. While wedges reduce medial tibial cartilage stress, a major RCT found no significant difference in medial cartilage volume loss versus controls over 12 months via MRI. Bone marrow lesions and cartilage defects progressed similarly, suggesting wedges excel at symptom control rather than disease modification.

Long-term use (e.g., with custom orthoses) maintains mechanical benefits without diminishing returns, supporting adherence for sustained function.

Types of Wedges and Application

Wedging comes in heel-only or full-length forms, made from firm materials like ethyl vinyl acetate. Heel wedges (5°) are simpler but less effective than full-length versions, which better control midfoot and forefoot motion.

Podiatrists often customize wedges, combining them with orthotics for foot-specific issues like overpronation, common in knee OA patients. Patients wear them bilaterally in daily shoes, replacing every 4 months, with trimmable options for fit.

Start with neutral shoes to avoid confounding pronation effects. Compliance is key—daily use yields best results.

Patient Selection and Limitations

Ideal candidates have symptomatic medial knee OA (mild-moderate severity), varus alignment, and no significant patellofemoral OA, as lateral load shifts can worsen anterior pain.

Contraindications include lateral OA, severe foot deformities, or non-responders identified via gait analysis. Women and older adults (e.g., >60 years) predominate in studies, reflecting OA epidemiology.

Limitations: Trials show equivocal structural benefits and variable pain response (22-28% minimal improvement rates). Cost-effectiveness favors wedges over pricier options, but real-world adherence drops without monitoring.

Integration into Podiatric Practice

As a podiatrist, assess via static (varus thrust) and dynamic (gait video) exams. Fabricate in-house: full-length 5° EVA wedges under orthotic shells for arch support.

Combine with strengthening (quadriceps/hip abductors), weight loss, and NSAIDs for multimodal care. Monitor at 4-8 weeks; switch to valgus bracing if unresponsive.

Leave a Reply

Your email address will not be published. Required fields are marked *